Skip to main content
. 2024 May 3;19(5):1345–1351. doi: 10.1007/s11739-024-03622-7

Table 5.

Valsalva analysis in patients with tVVS and controls

Parameter Syncope
(n = 21)
No syncope (n = 30) p-value
RR minimum phase 2 (ms) 710.7 ± 98.4 719.7 ± 125.0 0.78
RR maximum phase 4 (ms) 936 ± 166.2 959.5 ± 151.2 0.60
Valsalva ratio 1.3 ± 0.1 1.4 ± 0.2 0.53
Tachycardia ratio 0.8 ± 0.2 0.8 ± 0.1 0.45
Bradycardia ratio 1.0 ± 0.3 1.1 ± 0.2 0.26

RR  time between two successive R-waves